KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bancorp (TBBK) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Bancorp (TBBK) over the last 14 years, with Q3 2025 value amounting to $84.7 million.

  • Bancorp's Cash & Equivalents rose 5184.97% to $84.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.7 million, marking a year-over-year increase of 5184.97%. This contributed to the annual value of $570.1 million for FY2024, which is 4507.96% down from last year.
  • Bancorp's Cash & Equivalents amounted to $84.7 million in Q3 2025, which was up 5184.97% from $340.3 million recorded in Q2 2025.
  • In the past 5 years, Bancorp's Cash & Equivalents ranged from a high of $1.7 billion in Q1 2021 and a low of $18.7 million during Q4 2022
  • Its 5-year average for Cash & Equivalents is $622.0 million, with a median of $589.0 million in 2021.
  • In the last 5 years, Bancorp's Cash & Equivalents surged by 544772.34% in 2023 and then crashed by 9382.73% in 2024.
  • Quarter analysis of 5 years shows Bancorp's Cash & Equivalents stood at $68.4 million in 2021, then tumbled by 72.64% to $18.7 million in 2022, then skyrocketed by 5447.72% to $1.0 billion in 2023, then crashed by 45.08% to $570.1 million in 2024, then plummeted by 85.15% to $84.7 million in 2025.
  • Its last three reported values are $84.7 million in Q3 2025, $340.3 million for Q2 2025, and $1.0 billion during Q1 2025.